ACCEPTANCE OF SWITCH, PATIENT SATISFACTION AND ADVERSE EVENTS AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR SB5 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A REAL-LIFE SETTING

Thomas De Somer  1     Nele Deprez  1     Didier Baert  1     Mieke Deceuninck  2     Inge Huys  2     Veerle Mattens  3     An Sterckx  3     Stijn Vanden Branden  3     Erik Vanderstraeten  3     Jo Vandervoort  3     Nina Van Heddegem  3     Pieter Dewint  3    
1 AZ Maria Middelares, Gent, Belgium
2 Sint Vincentius Ziekenhuis, Deinze, Belgium
3 OLV Ziekenhuis, Aalst, Belgium

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing